Evidence map›Paper›PMID 36999006›Full record

ArticleHemaSphere2023

Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective?

Marta Riva, Alessandro Bosi, Lorenzo Rizzo, Federico Mazzon, Silvia Ferrari, Federico Lussana, Lorenza Borin, Andrea Castelli, Roberto Cairoli, Wilma Barcellini and 2 more

Open access · goldAbstract read
In one paragraph

Article in HemaSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Marta RivaDepartment of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Alessandro BosiHaematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Lorenzo RizzoDepartment of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Federico MazzonDepartment of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Silvia FerrariHematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Federico LussanaHematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Lorenza BorinDepartment of Hematology, San Gerardo Hospital, Monza, Italy.
Andrea CastelliHaematology, ASL Biella, Italy.
Roberto CairoliDepartment of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Wilma BarcelliniHaematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Alfredo MolteniHaematology, ASST Cremona, Italy.
Bruno FattizzoHaematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITOspedale Papa Giovanni XXIII · ITUniversity of Milan · ITAzienda Ospedaliera San Gerardo · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIstituti Ospitalieri di Cremona · ITOspedale degli Infermi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36999006
PMCPMC10047600
OpenAlexW4361212529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.